Brain Irradiation
Showing 1 - 25 of >10,000
Meningioma, Radiation Toxicity Trial in Caen, Rouen (Normo-fractionated intensity-modulated brain irradiation with or without
Recruiting
- Meningioma
- Radiation Toxicity
- Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning
- +3 more
-
Caen, France
- +1 more
Sep 13, 2023
Glioblastoma Multiforme Trial in Manchester (Preoperative brain irradiation (single fraction))
Recruiting
- Glioblastoma Multiforme
- Preoperative brain irradiation (single fraction)
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
Aug 2, 2022
Intracranial Meningioma Trial in Taoyuan (Radiation)
Not yet recruiting
- Intracranial Meningioma
- Radiation
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Apr 14, 2023
Metastatic Breast Cancer Trial in New York (Brain radiotherapy or Stereotactic Radiosurgery, Tremelimumab, HER2 directed
Completed
- Metastatic Breast Cancer
- Brain radiotherapy or Stereotactic Radiosurgery
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 2, 2022
Alzheimer Trial in Seoul (Low-dose whole brain irradiation)
Recruiting
- Alzheimer Disease
- Low-dose whole brain irradiation
-
Seoul, Korea, Republic ofKyung Hee University Hospital at Gangdong
Nov 22, 2022
Brain Metastases, Lung Cancer Trial in Duarte, Aurora, Rochester (Brigatinib)
Active, not recruiting
- Brain Metastases
- Lung Cancer
-
Duarte, California
- +2 more
Feb 8, 2022
Prophylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases Trial in Guiyang (Prophylactic Cranial Irradiation
Recruiting
- Prophylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases
- Prophylactic Cranial Irradiation for experiment arm
-
Guiyang, Guizhou, ChinaGuizhou Cancer Hospital
Aug 23, 2023
Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- +5 more
- Re-irradiation
- (no location specified)
Oct 16, 2023
Brain Tumor, Low Grade Glioma, Astrocytoma Trial in Boston (Proton radiotherapy)
Active, not recruiting
- Brain Tumor
- +4 more
- Proton radiotherapy
-
Boston, Massachusetts
- +1 more
Sep 30, 2021
Bladder Cancer Trial in Houston (Prophylactic Cranial Irradiation (PCI), Brain X-ray)
Active, not recruiting
- Bladder Cancer
- Prophylactic Cranial Irradiation (PCI)
- Brain X-ray
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 18, 2022
Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)
Not yet recruiting
- Small Cell Lung Cancer Limited Stage
- Prophylactic cranial irradiation
- +2 more
- (no location specified)
Dec 14, 2022
Metastatic Malignant Tumor in the Brain Trial in Rochester (Questionnaire Administration, Stereotactic Radiosurgery)
Recruiting
- Metastatic Malignant Neoplasm in the Brain
- Questionnaire Administration
- Stereotactic Radiosurgery
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by
Recruiting
- Recurrent High-grade Glioma
- +3 more
- 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
- +2 more
-
Incheon, Korea, Republic ofGachon University Gil Medical Center
Feb 19, 2023
Neurocognitive Deficit, Quality of Life, Activities of Daily Living Trial in Viagrande, Messina, Palermo (Stereotactic
Recruiting
- Neurocognitive Deficit
- +2 more
- Stereotactic RadioTherapy
- Whole Brain Irradiation
-
Viagrande, Catania, Italy
- +3 more
May 13, 2021
Cancer, Brain Metastases, Adult Trial in Copenhagen (Repeated stereotactic radiosurgery)
Recruiting
- Cancer
- Brain Metastases, Adult
- Repeated stereotactic radiosurgery
-
Copenhagen, DenmarkRigshospitalet, University of Copenhagen
Nov 8, 2021
Neurocognitive Trial in Guangzhou (Osimertinib and whole-brain irradiation, Osimertinib)
Recruiting
- Neurocognitive
- Osimertinib and whole-brain irradiation
- Osimertinib
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Cancer Center of Sun Yat-Sen Uni
Mar 31, 2021
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Brain Tumors, Adult, Malignant Trial in Dallas (Radiotherapy)
Completed
- Brain Neoplasms, Adult, Malignant
- Radiotherapy
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jan 5, 2021
Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)
Recruiting
- Recurrent Glioma
- +4 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology
Aug 19, 2021
Metastatic Malignant Tumor in the Brain, Stage IV NSCLC AJCC v7 Trial in Houston (procedure, biological, other, radiation)
Recruiting
- Metastatic Malignant Neoplasm in the Brain
- Stage IV Non-Small Cell Lung Cancer AJCC v7
- Cognitive Assessment
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- GDC-0084
- radiation therapy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 13, 2023
Malignant Tumor, Brain, Brain Tumor Trial in Los Angeles (other, radiation, procedure)
Withdrawn
- Malignant Neoplasm, Brain
- Brain Tumor
- Quality-of-Life Assessment
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jan 14, 2022
Recurrent Brain Tumor Trial in Houston (biological, other, radiation)
Active, not recruiting
- Recurrent Brain Neoplasm
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022